Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Burns : Journal of the International Society for Burn Injuries|January 26, 2023
European Burns Association guidelines for the management of burn mass casualty incidents within a European response planThomas Leclerc, Folke Sjöberg, Serge Jennes, et al.Cell and Tissue Banking|February 11, 2010
Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservationGilbert Verbeken, Dirck Schoeters, Gunther Verween, et al.Cell and Tissue Banking|March 2, 2011
Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungiGilbert Verbeken, Gunther Verween, Daniel De Vos, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|May 26, 2025
Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue ProductsGilbert Verbeken, Lieke Convents, Nicolas Delmotte, et al.Experimental Dermatology|February 24, 2015
Recellularizing of human acellular dermal matrices imaged by high-definition optical coherence tomographyMarc A L M Boone, Jean Pierre Draye, Gunther Verween, et al.Burns : Journal of the International Society for Burn Injuries|August 20, 2022
Burn mass casualty incidents in Europe: A European response plan within the European Union Civil Protection MechanismStian Kreken Almeland, Evelyn Depoortere, Serge Jennes, et al.The Lancet. Infectious Diseases|October 8, 2018
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trialPatrick Jault, Thomas Leclerc, Serge Jennes, et al.Cell and Tissue Banking|June 22, 2012
Beware of the commercialization of human cells and tissues: situation in the European UnionJean-Paul Pirnay, Alain Vanderkelen, Nadine Ectors, et al.Plos One|March 21, 2009
Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trialsMaya Merabishvili, Jean-Paul Pirnay, Gilbert Verbeken, et al.Plos One|May 26, 2016
Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound CenterDaniel De Vos, Jean-Paul Pirnay, Florence Bilocq, et al.Pageof 4